$13.94
1.48%
Nasdaq, Sep 29, 04:00 pm EDT. Closed.
ISIN
US6412881053
Symbol
NPCE

NeuroPace Inc Target price 2026 - Analyst rating & recommendation

NeuroPace Inc Classifications & Recommendation

Buy
93%
Hold
7%

NeuroPace Inc Price Target

Target Price $20.40
Price $13.94
Potential
Number of Estimates 11
11 Analysts have issued a price target NeuroPace Inc 2027 . The average NeuroPace Inc target price is $20.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 14 Analysts recommend NeuroPace Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the NeuroPace Inc stock has an average upside potential 2027 of . Most analysts recommend the NeuroPace Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 99.99 102.29
25.13% 2.30%
EBITDA Margin -16.10% -8.62%
40.04% 46.46%
Net Margin -21.47% -20.70%
36.78% 3.60%

11 Analysts have issued a sales forecast NeuroPace Inc 2026 . The average NeuroPace Inc sales estimate is

$102m
unlock
. This is
3.49% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$106m 7.41%
unlock
, the lowest is
$97.0m 1.84%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $100.0m 25.13%
2026
$102m 2.30%
unlock
2027
$125m 21.97%
unlock
2028
$155m 24.07%
unlock
2029
$181m 16.76%
unlock
2030
$188m 3.85%
unlock

10 Analysts have issued an NeuroPace Inc EBITDA forecast 2026. The average NeuroPace Inc EBITDA estimate is

$-8.8m
unlock
. This is
40.51% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-7.9m 46.86%
unlock
, the lowest is
$-9.3m 37.18%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-16.1m 24.98%
2026
$-8.8m 45.24%
unlock
2027
$-2.3m 73.49%
unlock
2028
$7.4m 417.42%
unlock

EBITDA Margin

2025 -16.10% 40.04%
2026
-8.62% 46.46%
unlock
2027
-1.87% 78.31%
unlock
2028
4.79% 356.15%
unlock

11 NeuroPace Inc Analysts have issued a net profit forecast 2026. The average NeuroPace Inc net profit estimate is

$-21.2m
unlock
. This is
10.83% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-13.0m 32.18%
unlock
, the lowest is
$-24.5m 28.31%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-21.5m 20.89%
2026
$-21.2m 1.35%
unlock
2027
$-10.6m 49.86%
unlock
2028
$-2.6m 75.61%
unlock
2029
$13.3m 613.13%
unlock

Net Margin

2025 -21.47% 36.78%
2026
-20.70% 3.60%
unlock
2027
-8.51% 58.89%
unlock
2028
-1.67% 80.38%
unlock
2029
7.35% 540.12%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.66 -0.62
29.03% 6.06%
P/E negative
EV/Sales 4.82

11 Analysts have issued a NeuroPace Inc forecast for earnings per share. The average NeuroPace Inc EPS is

$-0.62
unlock
. This is
8.77% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.38 33.33%
unlock
, the lowest is
$-0.72 26.32%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.66 29.03%
2026
$-0.62 6.06%
unlock
2027
$-0.31 50.00%
unlock
2028
$-0.08 74.19%
unlock
2029
$0.39 587.50%
unlock
2030
$0.37 5.13%
unlock

P/E ratio

Current -24.82 89.84%
2026
-22.90 7.75%
unlock
2027
-45.67 99.43%
unlock
2028
-187.47 310.49%
unlock
2029
36.51 119.48%
unlock

Based on analysts' sales estimates for 2026, the NeuroPace Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.99 32.36%
2026
4.82 3.41%
unlock
2027
3.95 18.01%
unlock
2028
3.19 19.40%
unlock
2029
2.73 14.35%
unlock
2030
2.63 3.70%
unlock

P/S ratio

Current 4.91 28.98%
2026
4.75 3.37%
unlock
2027
3.89 18.01%
unlock
2028
3.14 19.40%
unlock
2029
2.69 14.35%
unlock
2030
2.59 3.70%
unlock

Current NeuroPace Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Keybanc
Locked
➜
Locked
Locked Sep 18 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Jul 29 2026
Mizuho
Locked
➜
Locked
Locked Jul 23 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked May 15 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Jan 27 2026
UBS
Locked
➜
Locked
Locked Dec 16 2025
JP Morgan
Locked
➜
Locked
Locked Dec 10 2025
Analyst Rating Date
Locked
Keybanc:
Locked
➜
Locked
Sep 18 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Jul 29 2026
Locked
Mizuho:
Locked
➜
Locked
Jul 23 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
May 15 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Jan 27 2026
Locked
UBS:
Locked
➜
Locked
Dec 16 2025
Locked
JP Morgan:
Locked
➜
Locked
Dec 10 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today